Concepedia

Francisco O. Battiti

FO

Statistics

Publications

10

Citations

251

H-Index

10

Active since

2019

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

University of Southern California

Convergent Science (United States)

Francisco O. Battiti is an author at National Institute on Drug Abuse specializing in medicinal chemistry, pharmacology, and ligand binding.

ORCID

Publications per year

2019–2024

10

Publications

10

2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts

Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi · Journal of Medicinal Chemistry · 2019 · 72 citations · Full text

, , +17

The Significance of Chirality in Drug Design and Synthesis of Bitopic Ligands as D<sub>3</sub> Receptor (D<sub>3</sub>R) Selective Agonists

Francisco O. Battiti, Sophie Cemaj, Adrian M. Guerrero et al. · Journal of Medicinal Chemistry · 2019 · 40 citations · Full text

, , +17

Novel Dual-Target μ-Opioid Receptor and Dopamine D<sub>3</sub> Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management

Alessandro Bonifazi, Francisco O. Battiti, Julie Sanchez et al. · Journal of Medicinal Chemistry · 2021 · 26 citations · Full text

, , +17

Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells

Fabio Del Bello, Alessandro Bonifazi, Gianfabio Giorgioni et al. · European Journal of Medicinal Chemistry · 2019 · 23 citations · Full text

, , +6

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor

Pramisha Adhikari, Bing Xie, Ana Semeano et al. · Biomolecules · 2021 · 22 citations · Full text

, , +17

1–5 of 10